Bausch Health Companies Inc. (NYSE:BHC) Q3 2023 Earnings Call Transcript

Page 3 of 3

But clearly we’re excited about it. We think it’s a good opportunity to put this product in the bag to drive growth and stabilization of our medical derm business. Operator, next question?

Operator: We have reached the end of the question-and-answer session, and I will now turn the call over to Tom Appio for closing remarks.

Thomas Appio: Since there are no further questions, I would just say thank you for joining today. In summary, we had a solid Q3 and made good progress on our strategic objectives. We look forward to finishing the year strong with a focus on profitable growth, driving performance, advancing the R&D that we discussed on this call, and also advancing business development as well, and building on our overall momentum from the third quarter into the fourth, and then continuing that on in 2024. I would really like to thank everybody for joining our call today.

Operator: This concludes today’s conference, and you may disconnect your lines at this time. Thank you for your participation.

Follow Bausch Health Companies Inc. (NYSE:BHC)

Page 3 of 3